Deutsche Bank’s Purple Biotech PPBT Stock Holding History

Deutsche Bank’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Hold	0	–	–	–	5464
2019 Q1	–	Hold	0	–	–	–	5365
2017 Q4	–	Sell	-24	Closed	-$101K	–	5098
2017 Q3	$101K	Sell	24 -4	-14%	-$14.9K	﹤0.01%	4163
2017 Q2	$86K	Hold	28	–	–	﹤0.01%	4242
2017 Q1	$108K	Hold	28	–	–	﹤0.01%	3880
2016 Q4	$175K	Hold	28	–	–	﹤0.01%	3753
2016 Q3	$195K	Buy	+28	New	+$175K	﹤0.01%	3669

Other funds holding PPBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank's PPBT Position: Q2 2019 in Review

Deutsche Bank held its Purple Biotech (PPBT) position steady in Q2 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5464.

Deutsche Bank first reported a position in PPBT in Q3 2016 and has held it in 5 quarters since. The position peaked at $195K in Q3 2016. 5 funds tracked by Wall St. Rank hold PPBT as of Q2 2019.

Deutsche Bank held 0 shares of Purple Biotech worth $0 as of Q2 2019.
Deutsche Bank left its Purple Biotech share count unchanged in Q2 2019.
Purple Biotech made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2019, its #5464 holding.
Deutsche Bank first reported a position in Purple Biotech in Q3 2016 and has held it in 5 quarters since.
Deutsche Bank's Purple Biotech position peaked at $195K in Q3 2016.
5 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2019.

Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.